share_log

Raymond James Initiates Coverage On Aquestive Therapeutics With Outperform Rating, Announces Price Target of $7

Raymond James Initiates Coverage On Aquestive Therapeutics With Outperform Rating, Announces Price Target of $7

雷蒙德·詹姆斯以跑赢大盘的评级开始对Aquestive Therapeutics进行报道,宣布目标股价为7美元
Moomoo 24/7 ·  03/28 07:10

Raymond James analyst Gary Nachman initiates coverage on Aquestive Therapeutics (NASDAQ:AQST) with a Outperform rating and announces Price Target of $7.

雷蒙德·詹姆斯分析师加里·纳赫曼以跑赢大盘的评级启动了对Aquestive Therapeutics(纳斯达克股票代码:AQST)的报道,并宣布目标股价为7美元。

声明:本内容仅用作提供资讯及教育之目的,不构成对任何特定投资或投资策略的推荐或认可。 更多信息
    抢沙发